tiprankstipranks
Trending News
More News >
CombiGene AB (SE:LARK)
:LARK
Advertisement

CombiGene AB (LARK) Price & Analysis

Compare
0 Followers

LARK Stock Chart & Stats


LARK FAQ

What was CombiGene AB’s price range in the past 12 months?
CombiGene AB lowest stock price was kr1.27 and its highest was kr3.06 in the past 12 months.
    What is CombiGene AB’s market cap?
    CombiGene AB’s market cap is kr46.73M.
      When is CombiGene AB’s upcoming earnings report date?
      CombiGene AB’s upcoming earnings report date is Aug 22, 2025 which is in 27 days.
        How were CombiGene AB’s earnings last quarter?
        Currently, no data Available
        Is CombiGene AB overvalued?
        According to Wall Street analysts CombiGene AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does CombiGene AB pay dividends?
          CombiGene AB pays a Notavailable dividend of kr1.93 which represents an annual dividend yield of 8.62%. See more information on CombiGene AB dividends here
            What is CombiGene AB’s EPS estimate?
            CombiGene AB’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does CombiGene AB have?
            CombiGene AB has 19,801,197 shares outstanding.
              What happened to CombiGene AB’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of CombiGene AB?
              Currently, no hedge funds are holding shares in SE:LARK

              Company Description

              CombiGene AB

              CombiGene AB (COMBI) is a biotechnology company focused on the development of innovative gene therapy solutions to treat severe life-altering diseases. Operating within the healthcare sector, CombiGene specializes in leveraging cutting-edge genetic technologies to create therapies that address unmet medical needs. The company's core products are centered around gene therapy treatments, particularly in the areas of neurological disorders and metabolic diseases.
              Similar Stocks
              Company
              Price & Change
              Follow
              ExpreS2ion Biotech Holding AB
              Modus Therapeutics Holding AB
              OncoZenge AB
              Spago Nanomedical AB
              Sprint Bioscience AB
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis